| Item |
Information |
|
Drug Groups
|
approved |
|
Description
|
Antibiotic substance produced by Streptomyces garyphalus. [PubChem] |
| Indication |
Used in combination with up to 5 other drugs as a treatment for Mycobacterium avium complex (MAC) and is also used to treat tuberculosis (TB). |
| Pharmacology |
Cycloserine, a broad-spectrum antibiotic, may be bactericidal or bacteriostatic, depending on its concentration at the site of infection and the susceptibility of the organism. Cycloserine works by blocking the formation of these peptidoglycans. By doing this the walls of the bacteria become weak and it results in the death of the bacteria |
| Toxicity |
Oral LD50 in mouse is 5290 mg/kg, and in rat is over 5000 mg/kg. Symptoms of a cycloserine overdose include drowsiness, confusion, headache, dizziness, irritability, numbness and tingling, difficulty speaking, paralysis, abnormal behavior, seizures, and unconsciousness. |
| Affected Organisms |
| • |
Enteric bacteria and other eubacteria |
|
| Absorption |
Rapidly and almost completely absorbed (70 to 90%) from the gastrointestinal tract following oral administration. |
| Half Life |
Half-life in patients with normal renal function is 10 hours, and is prolonged in patients with impaired renal function. |
| External Links |
|
|